BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of 1x1 meeting with Analyst/Institutional Investor.07-02-2024
07-02-2024
Biocon gets tentative USFDA nod for cancer drug but share trades lower
The share touched a 52-week high of Rs 307 on February 6, 2024 and a 52-week low of Rs 191.60 March 21, 202307-02-2024
3 top stock picks from Aditya Arora for near term
So, my first buy is from Biocon which is buy at 296.15, price has inched up a little bit. Stop loss can be kept at 275, target can be Rs 320 to Rs 340.06-02-2024
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release05-02-2024
BIOCON LTD. - 532523 - Reminder Letter To Shareholders For Claiming Unclaimed Dividend And Updation Of KYC Information
Reminder Letter to shareholders for claiming unclaimed dividend and updation of KYC information31-01-2024
Buy Biocon; target of Rs 332: Sharekhan
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 332 in its research report dated January 17, 2024.18-01-2024
BIOCON LTD. - 532523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pls find enclosed certificate under regulation 74(5)11-01-2024
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meeting conducted with Investor / Analyst11-01-2024
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the Intimation for Earnings Call scheduled on February 09, 2024.10-01-2024